| Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ... Nature genetics 46 (8), 837-843, 2014 | 374 | 2014 |
| Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ... Nature genetics 48 (10), 1131-1141, 2016 | 356 | 2016 |
| Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case–control study CS Ross-Innes, I Debiram-Beecham, M O'Donovan, E Walker, ... PLoS medicine 12 (1), e1001780, 2015 | 270 | 2015 |
| Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry RJ Haidry, JM Dunn, MA Butt, MG Burnell, A Gupta, S Green, H Miah, ... Gastroenterology 145 (1), 87-95, 2013 | 263 | 2013 |
| Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study ACG van Baar, F Holleman, L Crenier, R Haidry, C Magee, D Hopkins, ... Gut 69 (2), 295-303, 2020 | 150 | 2020 |
| UK guidelines on oesophageal dilatation in clinical practice SS Sami, HN Haboubi, Y Ang, P Boger, P Bhandari, J De Caestecker, ... Gut 67 (6), 1000-1023, 2018 | 133 | 2018 |
| Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study CS Ross-Innes, H Chettouh, A Achilleos, N Galeano-Dalmau, ... The lancet Gastroenterology & hepatology 2 (1), 23-31, 2017 | 117 | 2017 |
| Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated … RJ Haidry, MA Butt, JM Dunn, A Gupta, G Lipman, HL Smart, P Bhandari, ... Gut 64 (8), 1192-1199, 2015 | 112 | 2015 |
| Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma F Noble, MA Lloyd, R Turkington, E Griffiths, M O'Donovan, JR O'Neill, ... Journal of British Surgery 104 (13), 1816-1828, 2017 | 102 | 2017 |
| Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts T Sawas, S Killcoyne, PG Iyer, KK Wang, TC Smyrk, JB Kisiel, Y Qin, ... Gastroenterology 155 (6), 1720-1728. e4, 2018 | 82 | 2018 |
| Identification of subtypes of Barrett’s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data SG Jammula, AC Katz-Summercorn, X Li, C Linossi, E Smyth, S Killcoyne, ... Gastroenterology 158 (6), 1682-1697. e1, 2020 | 79 | 2020 |
| Development of evidence-based surveillance intervals after radiofrequency ablation of Barrett’s esophagus CC Cotton, R Haidry, AP Thrift, L Lovat, NJ Shaheen Gastroenterology 155 (2), 316-326. e6, 2018 | 79 | 2018 |
| Artificial intelligence for the real-time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma: A … M Everson, LCGP Herrera, W Li, IM Luengo, O Ahmad, M Banks, ... United European gastroenterology journal 7 (2), 297-306, 2019 | 75 | 2019 |
| A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett’s oesophagus JM Dunn, GD Mackenzie, MR Banks, CA Mosse, R Haidry, S Green, ... Lasers in medical science 28, 707-715, 2013 | 69 | 2013 |
| Radiofrequency ablation for early oesophageal squamous neoplasia: outcomes form United Kingdom registry RJ Haidry, MA Butt, J Dunn, M Banks, A Gupta, H Smart, P Bhandari, ... World journal of gastroenterology: WJG 19 (36), 6011, 2013 | 67 | 2013 |
| Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett’s esophagus: a … MF Peerally, P Bhandari, K Ragunath, H Barr, C Stokes, R Haidry, L Lovat, ... Gastrointestinal endoscopy 89 (4), 680-689, 2019 | 64 | 2019 |
| Deep sedation and anaesthesia in complex gastrointestinal endoscopy: a joint position statement endorsed by the British Society of Gastroenterology (BSG), Joint Advisory Group … R Sidhu, D Turnbull, M Newton, S Thomas-Gibson, DS Sanders, ... Frontline gastroenterology 10 (2), 141-147, 2019 | 58 | 2019 |
| Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett’s esophagus: impact on treatment response and postprocedural pain SN van Munster, A Overwater, R Haidry, R Bisschops, JJ Bergman, ... Gastrointestinal Endoscopy 88 (5), 795-803. e2, 2018 | 57 | 2018 |
| Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 … G Mingrone, ACG Van Baar, J Devière, D Hopkins, E Moura, C Cercato, ... Gut 71 (2), 254-264, 2022 | 56 | 2022 |
| Expected value of artificial intelligence in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement H Messmann, R Bisschops, G Antonelli, D Libânio, P Sinonquel, ... Endoscopy 54 (12), 1211-1231, 2022 | 52 | 2022 |
